We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
Read MoreHide Full Article
Alpha Teknova (TKNO - Free Report) shares rallied 7.1% in the last trading session to close at $8.34. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.8% gain over the past four weeks.
Alpha Teknova’s share price gain can likely be attributed to continued investor interest following the company’s recent business updates, including its expansion of custom manufacturing capabilities and strong second-quarter results. The company introduced the Fill-Tek Dispensing System, a proprietary single-use bag technology that can fill custom reagent orders across multiple bag sizes and quantities as one lot. The system eliminates per-bag-size minimums, allowing manufacturers to order the bag formats and quantities that best fit their processes.
This maker of reagents used by the biopharmaceutical industry is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of +25%. Revenues are expected to be $11.8 million, up 12.9% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Alpha Teknova, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TKNO going forward to see if this recent jump can turn into more strength down the road.
Alpha Teknova is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Exelixis (EXEL - Free Report) , finished the last trading session 2% lower at $57.22. EXEL has returned 7.9% over the past month.
For Exelixis, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.89. This represents a change of +14.1% from what the company reported a year ago. Exelixis currently has a Zacks Rank of #3 (Hold).
View the Zacks #1 Rank List
Image: Bigstock
Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
Alpha Teknova (TKNO - Free Report) shares rallied 7.1% in the last trading session to close at $8.34. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.8% gain over the past four weeks.
Alpha Teknova’s share price gain can likely be attributed to continued investor interest following the company’s recent business updates, including its expansion of custom manufacturing capabilities and strong second-quarter results. The company introduced the Fill-Tek Dispensing System, a proprietary single-use bag technology that can fill custom reagent orders across multiple bag sizes and quantities as one lot. The system eliminates per-bag-size minimums, allowing manufacturers to order the bag formats and quantities that best fit their processes.
This maker of reagents used by the biopharmaceutical industry is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of +25%. Revenues are expected to be $11.8 million, up 12.9% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Alpha Teknova, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TKNO going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Alpha Teknova is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Exelixis (EXEL - Free Report) , finished the last trading session 2% lower at $57.22. EXEL has returned 7.9% over the past month.
For Exelixis, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.89. This represents a change of +14.1% from what the company reported a year ago. Exelixis currently has a Zacks Rank of #3 (Hold).